"We will continue to review opportunities as they
Post# of 148121
(Total Views: 696)
Posted On: 05/28/2024 11:44:56 AM
"We will continue to review opportunities as they arise, given the potential for significant value return at little or no cost to the Company." --- May 16, 2024
"and other opportunities the Company will be pursuing.." --- May 28, 2024
Now it's --- "Will be"
Can't forget also the non-dilutive intent.
Not to mention if an outstanding agreement is announced this week on the Colorectal trial --- no looking back.
Even without initial clinical results yet.
Shall see.....
"and other opportunities the Company will be pursuing.." --- May 28, 2024
Now it's --- "Will be"
Can't forget also the non-dilutive intent.
Not to mention if an outstanding agreement is announced this week on the Colorectal trial --- no looking back.
Even without initial clinical results yet.
Shall see.....
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼